top of page

Dr. Mary Rose Burnham

 

Dr. Mary Rose Burnham received her BSc in Biology from Catholic University of America (Washington DC, USA), and her PhD in Microbiology from the University of Virginia (Charlottesville, VA, USA). Her thesis work focused on mechanisms of cellular transformation by activated SRC-family kinases.

 

Her work on growth factor receptor and integrin receptor signalling complexes and the role of tyrosine phosphorylation in the regulation of cell growth and proliferation has been published in several peer-reviewed manuscripts, including Oncogene and Molecular and Cellular Biology. She completed her post-doctoral studies at the Wadsworth Center, part of the New York State Department of Health, where she worked on the development of in vitro/chip-scale model systems for measuring gamma-aminobutyric acid (GABA) levels and ion channel activity of the GABA neuroreceptor.

 

While at the Wadsworth Center, she participated in the National Science Foundation’s Center for Nanobiotechnology, where she helped design and test lipid-membrane-based biomimetic surfaces for the detection of membrane-active compounds.

 

Dr. Burnham is currently a full-time science writer/editor and scientific consultant. Her areas of expertise include: microbiology, cell biology, cancer biology/oncology, neurochemistry, signal transduction, molecular biology, gene regulation, genetic models of disease, and clinical biomarkers/genetic markers of disease. Secondary areas of expertise include plant biology/genetics, ecology/bioremediation, and population-based studies. Her current research interests are in the area of emerging therapeutics and treatment strategies for cancer and cardiovascular diseases.

 

 

New headquarters

This month, Bioedit moved into its new Manchester offices...

Full article
bottom of right box
top of inner box
bottom of right box
top of inner box
bottom of right box
bottom of page